<HashMap><database>biostudies-literature</database><scores/><additional><submitter>de Freitas Galvao RL</submitter><funding>Governo Brasil</funding><funding>Ministério da Ciência, Tecnologia, Inovações e Comunicações</funding><funding>Foundation for Scientific and Technological Development and Support of Ceará</funding><funding>National Council for Scientific and Technological Development</funding><funding>Ministério da Ciência, Tecnologia e Inovação</funding><pagination>100628</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12719093</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29</volume><pubmed_abstract>This study evaluated the efficacy of different treatment regimens with PZQ against Schistosoma mansoni infection. Residents of the Patioba and Colônia Miranda villages (Sergipe, Brazil) with a confirmed diagnosis of S. mansoni infection were randomized into one of the study groups and treated with a standard dose of PZQ (Group 1); with two doses spaced 24 hours apart (Group 2); or with two doses spaced 30 days apart (Group 3). Efficacy was assessed 30 days after the final treatment, based on the detection of eggs in feces using the Kato-Katz (KK) method and on the detection of CAA in urine using the Up-Converting Particle Lateral Flow (UCP-LF) assay. A total of 88 participants, who tested positive for infection by KK and UCP-LF CAA at baseline, were included in the statistical analysis. Cu</pubmed_abstract><journal>International journal for parasitology. Drugs and drug resistance</journal><pubmed_title>Evaluating the efficacy of different praziquantel treatment regimens using egg and circulating anodic antigen (CAA) detection methods in a Schistosoma mansoni endemic area in northeastern Brazil.</pubmed_title><pmcid>PMC12719093</pmcid><funding_grant_id>BMD-0008-01273.01.01/22</funding_grant_id><funding_grant_id>18/2021</funding_grant_id><funding_grant_id>404966/2021</funding_grant_id><funding_grant_id>404966/2021-7/CNPq/MCTI/FNDCT N\u00B0 18/2021</funding_grant_id><pubmed_authors>da Silva AM</pubmed_authors><pubmed_authors>Barbosa L</pubmed_authors><pubmed_authors>van Dam GJ</pubmed_authors><pubmed_authors>de Freitas Galvao RL</pubmed_authors><pubmed_authors>Pinheiro MCC</pubmed_authors><pubmed_authors>de Moraes Bezerra FS</pubmed_authors><pubmed_authors>Corstjens PLAM</pubmed_authors><pubmed_authors>Hoekstra PT</pubmed_authors><pubmed_authors>Cesar Souza Sa SL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluating the efficacy of different praziquantel treatment regimens using egg and circulating anodic antigen (CAA) detection methods in a Schistosoma mansoni endemic area in northeastern Brazil.</name><description>This study evaluated the efficacy of different treatment regimens with PZQ against Schistosoma mansoni infection. Residents of the Patioba and Colônia Miranda villages (Sergipe, Brazil) with a confirmed diagnosis of S. mansoni infection were randomized into one of the study groups and treated with a standard dose of PZQ (Group 1); with two doses spaced 24 hours apart (Group 2); or with two doses spaced 30 days apart (Group 3). Efficacy was assessed 30 days after the final treatment, based on the detection of eggs in feces using the Kato-Katz (KK) method and on the detection of CAA in urine using the Up-Converting Particle Lateral Flow (UCP-LF) assay. A total of 88 participants, who tested positive for infection by KK and UCP-LF CAA at baseline, were included in the statistical analysis. Cu</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-08T05:27:43.402Z</modification><creation>2026-06-08T03:08:55.703Z</creation></dates><accession>S-EPMC12719093</accession><cross_references><pubmed>41337908</pubmed><doi>10.1016/j.ijpddr.2025.100628</doi></cross_references></HashMap>